TEPADINA 400 mg, powder and solvent for solution for infusion bag
Active ingredients: THIOTÉPA
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder and solvent for solution for infusionbagintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TEPADINA 400 mg, poudre et solvant pour solution pour perfusion
- Pharmaceutical form
- poudre et solvant pour solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 poche à compartiment double copolymère (polypropylène/styrène) de 400 mg de poudre et 400 mL de solvant suremballée(s)/surpochée(s) aluminium
- Marketing authorisation holder
- ADIENNE (ITALIE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 8 Mar 2022
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62280018CIP75508272CIP133400955082729Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| THIOTÉPApoudre | 400 mg · une poche | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.